A study to estimate the COVID-19 vaccine demand and hesitancy towards it in Shivpuri Central India.

Background: Humans have become the witnessed of three deadly pandemics so far in the twenty-first century which are associated with novel corona viruses. All of these viruses, which are responsible for causing acute respiratory tract infections. Since the emergence of the 2019 novel corona virus (2019-nCoV) infection in Wuhan, China, in December 2019. Objective: 1. To assess the sociodemographic profile of the population. 2. To assess the public response about the covid-19 vaccine demand. 3. The various causes of hesitancy against vaccine acceptance. Method: A cross-sectional study was conducted in urban shivpuri population of above 18 year who are eligible for COVID-19 vaccination after applying inclusion and exclusion criteria during the February 2020-to April 2020. Data was collected by subordinate staff after giving offline training to them by face to face interview to each participant on predesigned and pretested close ended questionnaire. Result: In the present study we found that most common age group was 41-60 year male education middle class. We found that age, sex and religion not have any significance effect on their willingness for taking the vaccine but we found that education and people who have any co-morbidity was play the significance difference about their willingness to wards the acceptance of vaccine against COVID. Conclusion: We concluded that the people have hesitance about the acceptance of the COVID-19 vaccine in which most common reason was Not sure about its effectiveness on the other strain of the Covid-19 virus followed by they felt that after taking the vaccine we were not protect by it 100%.Conclusion: We concluded that the people have hesitance about the acceptance of the COVID-19 vaccine in which most common reason was Not sure about its effectiveness on the other strain of the Covid-19 virus followed by they felt that after taking the vaccine we were not protect by it 100%. [ABSTRACT FROM AUTHOR]